Shineroad International Holdings Ltd

Shineroad's capital structure is characterized by a low debt-to-equity ratio of 0.18 and a strong current ratio of 5.9, indicating robust liquidity and short-term solvency. The company's liquidity FPT score of 8.2 suggests a conservative balance sheet with ample cash and equivalents of CNY 186.8 million, which is 25.8% of total assets. The price-to-book ratio of 0.74 and tangible book ratio of 0.74 imply that the market values the company below its net asset value, potentially reflecting cautious investor sentiment or undervaluation. Profitability metrics show a return on equity (ROE) of 10.65% and return on assets (ROA) of 7.96%, both above the industry median for Food Processing firms. The gross margin of 18.56% (CNY 120.9 million gross profit on CNY 651.5 million revenue) is in line with sector norms, but the operating margin of 12.5% (CNY 81.5 million operating income) suggests efficient cost control. Net income of CNY 57.6 million represents a 8.84% margin, which is competitive within the industry. Geographically, Shineroad's revenue is concentrated in China, with no disclosed overseas revenue breakdown. The company's segmental exposure is not fully transparent, but its product portfolio spans beverage, dairy, bakery, and other food categories. This diversification reduces single-product risk but may also dilute focus in high-growth areas. Outlook data indicates a 12.3% revenue growth in the current fiscal year and a 9.1% increase in the next, driven by new manufacturing centers and expanded supplier partnerships. Free cash flow of CNY 5.4 million is modest but positive, with capital expenditures of CNY 39.6 million reflecting ongoing investment in infrastructure. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position mitigate credit risk, but its reliance on supplier relationships and domestic market exposure could pose operational risks if global supply chains or Chinese demand fluctuate. No dilution pressure is currently evident, with basic and diluted shares outstanding aligned at 680 million. Recent filings and transcripts do not highlight material events, but the company's strategic investments in Food Corporations and R&D suggest a focus on long-term growth. No significant regulatory or litigation risks were identified in the latest disclosures.